Michael Nebauer
InvestorDirector, Execution at Clear Haven Capital Management
Find your path to Michael
18 people in our graph share verified history with Michael — schools, employers, funds. One of them is your warm intro.
About
Michael Nebauer is President and CEO of the Ontario Bioscience Innovation Organization (OBIO), a not-for-profit focused on health technology innovation and commercialization, where he previously served as Chair of the Board of Directors from November 2019 to February 2022. His prior roles include Vice-President of Intellectual Property and Contracts at Turnstone Biologics and Director of Intellectual Property at VBI Vaccines, along with positions at the Ottawa Hospital Research Institute, PainCeptor Pharma Corporation, and the Institute for Robotics and Intelligent Systems National Centre of Excellence. He holds a Ph.D. in biochemistry from the University of Ottawa and an M.Sc. and B.Sc. in biochemistry from Queen's University.
Colleagues at Clear Haven Capital Management
Frequently asked questions
- Who is Michael Nebauer?
- Michael Nebauer is President and CEO of the Ontario Bioscience Innovation Organization (OBIO), a not-for-profit focused on health technology innovation and commercialization, where he previously served as Chair of the Board of Directors from November 2019 to February 2022. His prior roles include Vice-President of Intellectual Property and Contracts at Turnstone Biologics and Director of Intellectual Property at VBI Vaccines, along with positions at the Ottawa Hospital Research Institute, PainCeptor Pharma Corporation, and the Institute for Robotics and Intelligent Systems National Centre of Excellence. He holds a Ph.D. in biochemistry from the University of Ottawa and an M.Sc. and B.Sc. in biochemistry from Queen's University.
- Where does Michael Nebauer work?
- Michael Nebauer is Director, Execution at Clear Haven Capital Management.